Chargement en cours...
Progress With Developing Use of Gene Editing To Cure Chronic Infection With Hepatitis B Virus
Chronic infection with hepatitis B virus (HBV) occurs in approximately 6% of the world's population. Carriers of the virus are at risk for life-threatening complications, and developing curative treatment remains a priority. The main shortcoming of licensed therapies is that they do not affect...
Enregistré dans:
| Publié dans: | Mol Ther |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4886943/ https://ncbi.nlm.nih.gov/pubmed/26916283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2016.43 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|